Corbus Pharmaceuticals Holdings, Inc. (CRBP) Stock

Healthcare · Biotechnology · Member of Other US Stocks

Corbus Pharmaceuticals Holdings, Inc. (CRBP) closed at USD 4.41 on 2026-10-14, a change of -74.2 % over the past year, with a market capitalization of USD 83.75M.

Corbus Pharmaceuticals Holdings, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Corbus Pharmaceuticals Holdings, Inc. key figures

Previous close

USD 4.41 (2026-10-14)

1-year change

-74.2 %

Market cap

USD 83.75M

Enterprise value

USD -29.93M

P/E ratio (trailing)

-0.78

P/E ratio (forward)

-0.79

EPS (trailing)

-5.55

EPS (forward)

-5.51

PEG ratio

n/a

Price to book

0.79

Revenue growth

n/a

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

2.35

Employees

36

Analyst consensus (third-party)

strong_buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Corbus Pharmaceuticals Holdings, Inc.

Corbus Pharmaceuticals Holdings, Inc., a clinical stage company, develops and commercializes therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E; and CRB-913, a peripherally restricted cannabinoid type-1 receptor inverse agonist for the treatment of obesity. The company was incorporated in 2009 and is headquartered in Norwood, Massachusetts.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Corbus Pharmaceuticals Holdings, Inc. and compare it with other stocks.